Involvement of obesity in carsinogenesis of uterine endometrial cancer
Involvement of obesity in carsinogenesis of uterine endometrial cancer
批准号:
13671737
负责人:
TAMURA Takaya
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: Exon 5 or exon 7 altematively spliced estrogen receptors (△5, △7) have been reported to act dominant positive or dominant negative respectively in vitro, but it is not certain whether or how they are concerned with variant kinds of endometrial disease and what function they have in vivo. This study was designed to examine the role of those receptors in endometrial disease., especially endometrial cancer and the concern of leptin in alternative splicing of themMethods: By quantitative RT-PCR methods, we measured △5, △7 and wild type estrogen receptor (Wt) mRNAs in normal human endometrial (n=96), endometrial hyperplasia (n=7) and endometrial cancer (n=52). In endometrial cancer tissue, we also measured ER and PR protein by EIA. To examine the effect of leptin on altemative splicing of Erα, Ishikawa endometrial cancer cell was cultured with variant concentration of leptin, and the expression of Wt, △5, △7 mRNA were measuredResults: In normal human endometrium, the expression … More of △5, △7 mRNAs showed menstrual cycle, which were different from that of Wt Mrna. The each expression ratio of △5, △7 against Wt mRNAs (△5/Wt, △7/Wt) over 1.0 seldom occur in normal endometrium but in endometrialpolyp, endometrial hyperplasia and endmetrial cancer tissue, 44%, 43% and 40% of the cases showed high expression ratio of △5/Wt over the range in normal endometrium. As for △7.27% of endometrial cancer cases showed high △7/Wt expression ratio. On the other hand, no remarkable evidence that △5 or △7 works as dominant positive or negative on the expression of PR in vivo. Leptin increased the expression of △5 mRNA significantly in a dose and time dependent manner, and it also showed the effect to stimulate the cell growthConclusions: In normal human endometrium, the expression of △5 and △7 Mrna were regulated strictly and independenthly. They have some physiological function in vivo, but they were suppsed to be covered by that of Wt in estrogen sufficient circumstances. The regulation factor(s) and the function were supposed to be different from those of Wt in vivo. The deregulation of △5 or △7 Mrna expression seldom occur in normal endometrium, but can occur not only in benign but also in malignant endometrial disease. In obesity women, after menopause, high concentration of leptin in peripheral serum can work on endometrial cells to increase the expression of △5. On carcinogenesis of endometrial cancer, after menopause, with high concentration of leptin due to obesity, the increse of △5 expression was supposed to work on maintaining cellular activity under estrogen deprived circumstances. It provided a base to the following irreversible genetic changes toward carcinogenesis. And in endometrial cancer tissue, the deregulated expression of those receptors may contribute to the advancing of the tumor Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
西方饮食通过“肠道菌群-Rspo1”轴促进肥胖与肠道吸收的机制研究
-
批准号:82370845
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:洪洁
-
依托单位:
SUCLA2失调控介导的琥珀酸代谢异常促进巨噬细胞炎性活化及肥胖发生
-
批准号:32000525
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:蒋昊文
-
依托单位:
肥大细胞与脂肪细胞互作调控长期高脂饮食小鼠附睾脂肪组织萎缩重构的机制
-
批准号:32070757
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:刘健
-
依托单位:
SerRS在三阴性乳腺癌脂代谢失调中的作用机制及靶向干预
-
批准号:32070752
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:史毅
-
依托单位:
ISLR参与肥胖小鼠胰岛素抵抗的机制研究
-
批准号:31970712
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:孟庆勇
-
依托单位:
生长激素信号降低与肥胖发生关系的分子机制研究
-
批准号:81170814
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:王向东
-
依托单位:
基于MicroPET棕色脂肪显像技术的肥胖发病机制及调控因素的研究
-
批准号:81101074
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:程午樱
-
依托单位:
深入研究chemerin/GPR1信号系统在脂肪细胞分化和肥胖病中的作用机制
-
批准号:31100850
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:张键
-
依托单位:
环境与遗传危险因素对青少年肥胖影响的出生队列研究
-
批准号:81072364
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:武俊青
-
依托单位:
Apicidin启动成熟脂肪细胞去分化的分子信号机制研究
-
批准号:81071589
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:高建华
-
依托单位: